05Aug
Defying gravity: US M&A H1 2019: Pharma chases innovation through deals
The need to replenish intellectual property has pushed the pharma industry to the highest-performing sector by M&A value. In the pharmaceuticals, medical and biotech sector, deal value in the first half of the year was up 142 percent to US$172...
By:
White & Case LLP
Related
By now, you most likely have heard the phrase “OK Boomer.” What began as a meme, quickly went vir...
Read More >
Millennials, can you relate to your older co-workers? Everybody and their dog has workshops these d...
Read More >
In its May 2019 opinion in Vazquez v. Jan-Pro Franchising Int’l, Inc., the Ninth Circuit held that ...
Read More >
Following the enactment of the Competition Amendment Act during 2019 and the subsequent promulgation...
Read More >
In 2020, Ohio’s development officials are again awarding grants to fund commercial and industrial d...
Read More >
In a growing technological and global marketplace, the labor market is expanding to accommodate the ...
Read More >